Proteomics-derived basal biomarker DNA-PKcs is associated with intrinsic subtype and long-term clinical outcomes in breast cancer.

Asleh, Karama; Riaz, Nazia; Cheng, Angela S; Gao, Dongxia; Leung, Samuel C Y; Anurag, Meenakshi; Nielsen, Torsten O

Asleh, Karama; Riaz, Nazia; Cheng, Angela S; Gao, Dongxia; Leung, Samuel C Y; Anurag, Meenakshi; Nielsen, Torsten O.

Afiliação

Asleh K; Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
Riaz N; Interdisciplinary Oncology Program, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
Cheng AS; Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
Gao D; Centre for Regenerative Medicine and Stem Cell Research, Aga Khan University, Karachi, Pakistan.
Leung SCY; Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
Anurag M; Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
Nielsen TO; Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.

NPJ Breast Cancer ; 7(1): 114, 2021 Sep 09.

Article em En | MEDLINE | ID: mdl-34504086

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google